print_label | resize_label

SITE MAP

FARXIGA Overview

 

Home

 

Clinical Efficacy

 

INITIAL THERAPY WITH FARXIGA

5 mg Combination With Metformin XR

10 mg Combination With Metformin XR

5 mg and 10 mg Monotherapy

 

FARXIGA AS ADD-ON THERAPY

To Metformin

To Sitagliptin (a DPP-4i)

To Glimepiride (a Sulfonylurea)

To Pioglitazone (a Thiazolidinedione)

 

FARXIGA AS ADD-ON TO INSULIN

± Oral Antidiabetic(s)

 

HEAD-TO-HEAD DATA WITH FARXIGA + METFORMIN

Vs Glipizide (a Sulfonylurea) + Metformin: 1-Year Data

Vs Glipizide (a Sulfonylurea) + Metformin: 2- and 4-Year Data

 

ADDITIONAL BENEFITS OF FARXIGA*

Weight Reductions

Blood Pressure Reductions in Combination With Metformin

 

*Weight and blood pressure reductions were secondary and additional end points. Change in A1C was evaluated as the primary end point.

Safety Profile

 

Dosing & Administration

 

Science of FARXIGA

 

Access & Savings Card

 

Patient Dialogue

 

Register

 

Contact Us

 

AstraZeneca US Corporate Site

 

Privacy Notice

 

Legal Statement

 

Prescribing Information

*Weight and blood pressure reductions were secondary and additional end points. Change in A1C was evaluated as the primary end point.